Hello everybody. Welcome back. Fancy seeing you here. And thanks for listening to Psychedetics Weekly. This is David Drabkin in a weekly episode alongside Catherine Tucker,

who's from the National Psychedelic Association. There's been so much happening around the world,

but especially here in America with psychedelic regulations and bills and legislation. So we thought,

let's dive in with Catherine and really approach all of

these legal issues together, but especially what Catherine has been working on for a long,

long time decades, is the right to try and the breakthrough therapies act, which is now coming

down the pipeline and could potentially reschedule psilocybin.

So really interesting to get into the nuts and bolts of that. We talk about what's happening

in Australia this week, massive news coming out there. And then we also, at the very end,

talk about the end of the public health emergency and the return of the Ryan Weight Act. And what does that mean

for ketamine telehealth companies? All right. So if you have not yet subscribed to psychedelics

today, wherever you listen to podcasts, please go and do it. Like and subscribe helps people find us.

And on social media, we're there. Find us if you haven't yet like us and just check out what

we're sharing with our podcasts, with our articles and events. To check them out in more detail,

go to psychedelicsday.com. Our trainings on psychedelic education center.com. Applications for

vital are open now until March 19th, early bed till March 3rd,

and convergence tickets are selling. So if you want to check that out, then feel free to go

to our website, psychilicidavit.com slash convergence. And if you're feeling generous,

patreon.com slash psychedelics today. I should write them down and I'll just have them all in my

head. All right, folks, enjoy the show, everyone. God bless.

All right. Welcome to the show, everybody. I'm sitting here in discussion with Catherine

Tucker. Love you to have you back on the show. Catherine, how are you doing?

...